METHYLERGOMETRINE
Background and Date of Approval
The United States Food and Drug Administration (FDA) approved methylergometrine on 29 June 1948.
Uses
Methylergometrine is utilized to prevent or treat excessive bleeding following childbirth or abortion. Belonging to the ergot alkaloid class of drugs, it induces uterine contractions, aiding in the reduction of postpartum hemorrhage by promoting the closure of blood vessels within the uterus.
How is it administered?
Methylergometrine is usually administered as an intramuscular injection, though it can also be given orally or intravenously, depending on the situation and the healthcare provider's judgment.
Side Effects
Common side effects of Methylergometrine include nausea, vomiting, headache, uterine cramps, and increased blood pressure. More serious side effects may include chest pain, seizures, severe headaches, and hypertensive crisis (dangerously high blood pressure).
Warnings
Methylergometrine can cause a sudden and severe increase in blood pressure, leading to hypertensive crisis. The medication's vasoconstrictive properties can impact the cardiovascular system, potentially causing chest pain, irregular heartbeats, and other heart-related issues. It can trigger seizures, especially in individuals with a history of seizure disorders. Due to its potential to affect blood pressure and blood vessels, may increase the risk of stroke, especially in individuals with preexisting risk factors.
Precautions
Individuals with hypertension or high blood pressure should use Methylergometrine cautiously due to its potential to increase blood pressure further. People with heart conditions, angina, or a history of heart problems should use this medication cautiously due to its impact on cardiovascular function. Its use may require caution or dose adjustment in individuals with severe liver or kidney impairment.
Word of Advice
Patients with hypertension, cardiac disease, or prior cardiac events require caution, as methylergometrine elevates blood pressure and may affect cardiac function. Use with care in patients with hepatic or renal impairment. Patients with peripheral vascular disease or migraine should exercise caution. Inform your doctor if you are pregnant or breastfeeding, particularly if you have preeclampsia or placental complications. Methylergometrine may interact with other medications, alcohol, and grapefruit juice; avoid concurrent use. Dizziness may occur and may impair driving or operation of machinery. Disclose your complete medical history to your doctor, including seizure disorder and drug allergies. While methylergometrine is indicated for post-partum haemorrhage, it may be unsuitable in other acute situations. Monitor for serious adverse effects including severe headache or chest pain. Adhere to your doctor's prescribed instructions and seek clarification if uncertain.
References
Novartis Pharmaceuticals Corporation, US Food & Drug Administration, [Revised on June 2012] [Accessed on 31st Aug 2023],/ https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/006035s078lbl.pdf hameln pharma ltd, Electronic medicines compendium (EMC), [ Revised on31st Aug 2023] [Accessed on August 31st, 2023], https://www.medicines.org.uk/emc/product/6265/smpc#gref
Frequently Asked Questions
Is Methylergometrine safe for women with a history of migraines?
Methylergometrine might trigger migraines in some cases, so discuss your medical history with your doctor.
Can men use Methylergometrine?
It's primarily used in postpartum women and not intended for use in men.
Can I stop taking Methylergometrine if I feel better?
No, completing the full course as your doctor prescribes is important to ensure its effectiveness.
Can Methylergometrine be used in emergencies other than childbirth?
It's primarily used for preventing or managing postpartum bleeding. Its use in other emergencies depends on your doctor's recommendation.
How long do I need to use Methylergometrine?
The duration of use depends on your specific situation and your doctor's recommendation.
Can Methylergometrine cause changes in blood pressure?
Yes, Methylergometrine can lead to increased blood pressure, which is why its use should be closely monitored, especially in individuals with hypertension.